Elevated blood pressure and enhanced myocardial contractility in mice with severe IGF-1 deficiency

被引:116
作者
Lembo, G
Rockman, HA
Hunter, JJ
Steinmetz, H
Koch, WJ
Ma, L
Prinz, MP
Ross, J
Chien, KR
PowellBraxton, L
机构
[1] UNIV CALIF SAN DIEGO, DEPT MED, 0613C, AMER HEART ASSOC BUGHER FDN CTR MOL BIOL, LA JOLLA, CA 92093 USA
[2] UNIV CALIF SAN DIEGO, CTR MOL GENET, LA JOLLA, CA 92093 USA
[3] UNIV CALIF SAN DIEGO, DEPT PHARMACOL, LA JOLLA, CA 92093 USA
[4] DUKE UNIV, DEPT SURG, DURHAM, NC USA
[5] GENENTECH INC, S SAN FRANCISCO, CA 94080 USA
关键词
insulin-like growth factor I; mutagenesis; site-directed; myocardial contraction; hypertension; adrenergic receptors; beta receptors;
D O I
10.1172/JCI119086
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
To circumvent the embryonic lethality of a complete deficiency in insulin-like growth factor 1 (IGF-1), we generated mice homozygous for a site-specific insertional event that created a mutant IGF-1 allele (igf1(m)). These mice have IGF-1 levels 30% of wild type yet survive to adulthood, thereby allowing physiological analysis of the phenotype. Miniaturized catheterization technology revealed elevated conscious blood pressure in IGF-1(m/m) mice, and measurements of left ventricular contractility were increased. Adenylyl cyclase activity was enhanced in IGF-1(m/m) hearts, without an increase in beta-adrenergic receptor density, suggesting that crosstalk between IGF-1 and beta-adrenergic signaling pathways may mediate the increased contractility. The hypertrophic response of the left ventricular myocardium in response to aortic constriction, however, was preserved in IGF-1(m/m) mice. We conclude that chronic alterations in IGF-1 levels can selectively modulate blood pressure and left ventricular function, while not affecting adaptive myocardial hypertrophy in vivo.
引用
收藏
页码:2648 / 2655
页数:8
相关论文
共 46 条
[1]   THE VASODILATOR ACTION OF INSULIN - IMPLICATIONS FOR THE INSULIN HYPOTHESIS OF HYPERTENSION [J].
ANDERSON, EA ;
MARK, AL .
HYPERTENSION, 1993, 21 (02) :136-141
[2]  
BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O
[3]   PHYSIOLOGICAL-EFFECTS OF INVERSE AGONISTS IN TRANSGENIC MICE WITH MYOCARDIAL OVEREXPRESSION OF THE BETA(2)-ADRENOCEPTOR [J].
BOND, RA ;
LEFF, P ;
JOHNSON, TD ;
MILANO, CA ;
ROCKMAN, HA ;
MCMINN, TR ;
APPARSUNDARAM, S ;
HYEK, MF ;
KENAKIN, TP ;
ALLEN, LF ;
LEFKOWITZ, RJ .
NATURE, 1995, 374 (6519) :272-276
[4]   ADRENOCEPTOR-MEDIATED CARDIAC AND VASCULAR-RESPONSES IN GENETICALLY GROWTH HORMONE-DEFICIENT RATS [J].
BROWN, L ;
WYSE, B ;
SERNIA, C .
BIOCHEMICAL PHARMACOLOGY, 1993, 45 (11) :2223-2229
[5]   MOLECULAR ADVANCES IN CARDIOVASCULAR BIOLOGY [J].
CHIEN, KR .
SCIENCE, 1993, 260 (5110) :916-917
[6]   CARDIAC-MUSCLE DISEASES IN GENETICALLY-ENGINEERED MICE - EVOLUTION OF MOLECULAR PHYSIOLOGY [J].
CHIEN, KR .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1995, 269 (03) :H755-H766
[7]   LINKAGE OF 11-BETA-HYDROXYLASE MUTATIONS WITH ALTERED STEROID-BIOSYNTHESIS AND BLOOD-PRESSURE IN THE DAHL RAT [J].
CICILA, GT ;
RAPP, JP ;
WANG, JM ;
STLEZIN, E ;
NG, SC ;
KURTZ, TW .
NATURE GENETICS, 1993, 3 (04) :346-353
[8]   Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat - A combined in vivo and in vitro evaluation [J].
Cittadini, A ;
Stromer, H ;
Katz, SE ;
Clark, R ;
Moses, AC ;
Morgan, JP ;
Douglas, PS .
CIRCULATION, 1996, 93 (04) :800-809
[9]   RECOMBINANT HUMAN INSULIN-LIKE GROWTH-FACTOR-I INCREASES FOREARM BLOOD-FLOW [J].
COPELAND, KC ;
NAIR, KS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (01) :230-232
[10]  
CZERWINSKI SM, 1993, MED SCI SPORT EXER, V25, P495